About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Statins and Omega-3 Fatty Acid Combination can Reduce Risk of Cardiovascular Disease

by Kathy Jones on May 2, 2014 at 10:47 PM
 Statins and Omega-3 Fatty Acid Combination can Reduce Risk of Cardiovascular Disease

Combining statins with eicosapentaenoic acid (EPA), an omega-3 fatty acid, can help reduce the risk of cardiovascular disease, a new study conducted by researchers at Brigham and Women's Hospital (BWH) and which has been presented at the National Lipid Association Scientific Sessions in Orlando, Florida, reveals.

"We know that endothelial cell dysfunction is emerging as an early and important predictor of cardiovascular disease and plays an essential role in plaque development. Treatments that provide beneficial effects on endothelial function could have very important implications for a patient population at high risk for heart disease," said R. Preston Mason, PhD, of BWH's Department of Medicine and lead author of the study. "We found that a combination of statins and EPA omega-3 fatty acid, or fish oil, had beneficial effects on endothelial cells and function."

Advertisement

Using human tissue, researchers analyzed whether EPA could enhance the benefits of statins on endothelial cells. Blood vessels from human umbilical vein cells were collected from healthy donors and then subjected to disease-like conditions in the laboratory using oxidized low-density lipoproteins (LDL). Using nanotechnology approaches, researchers measured the release of molecules from the endothelial cells including nitric oxide, an essential regulator of blood vessel health. The researchers found that the combination of EPA and a statin was more than 50 percent better than the statin alone in reversing endothelial damage.

Researchers conclude that there is a potent and favorable interaction between the omega-3 fatty acid, EPA, and widely used statins, and suggest that a therapeutic strategy with this combination may be beneficial patients with increased risk for CV disease.
Advertisement

These new results may also underscore the importance of coupling high-quality statin therapies with an omega-3 agent such as EPA in potentially reducing cardiovascular risk, in addition to treating elevated triglycerides. High circulating triglyceride levels are considered a risk factor associated with cardiovascular disease, along with HDL, LDL cholesterol and blood pressure. New strategies to help patients manage this aspect of cardiovascular risk show promise in the overall prevention and treatment of heart disease.

The researchers note that future research is needed, particularly in humans, including cardiovascular outcomes data in randomized clinical trials.
Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Heart Disease News

Gender Disparity in Heart Health: Women at 25% Greater Risk of Heart Diseases
World Heart Day 2023: Many women face difficulties when it comes to accessing healthcare services, including cardiovascular screening, preventive care, and treatment.
How Hot Flashes and Cardiovascular Risk Factors Tied-Up?
Midlife women approaching menopause experience hot flashes which are linked to increased systemic inflammation, a risk factor for heart diseases.
Etripamil Nasal Spray - Quick & Simple Fix for High Heartrate
Patients with tachycardia (fast heart rate) can quickly return to normal heart rhythm with a self-administered etripamil nasal spray.
Doctors Urge Action on Rising Heart Disease Burden
Every year on September 29, World Heart Day is observed to promote awareness of heart-related diseases and seek solutions for heart disease prevention and management.
Global Heart Failure Cases Projected to Exceed 16 Million by 2032
While heart failure can affect both genders, it is more commonly observed in men and is more prevalent in the elderly population.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Statins and Omega-3 Fatty Acid Combination can Reduce Risk of Cardiovascular Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests